144 results found
View 10, 50, 100, 150 entries per page
| Journal | Year | Drug | Authors | Title | Source |
|---|---|---|---|---|---|
| Pediatrics | 2002 | Recombinant Activated Factor VII | Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, SupapannachartS | The Use of Recombinant Activated Factor VII to Control Bleeding in a Preterm Infant Undergoing Exploratory Laparotomy | Pediatrics 2002 July; 110 (1): 169-171 |
| Pediatrics | 2002 | Ribavirin | Gavin PJ, Katz BZ | Intravenous Ribavirin Treatment for Severe Adenovirus Disease in Immunocompromised Children | Pediatrics 2002 July; 110 (1): e9 |
| Pediatrics | 2002 | Rifampin | O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA. | Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disese Control and Prevention, u.s. | Pediatrics. 2002 Nov;110(5):e51 |
| Pediatrics | 2002 | Rotashield | Peter G, Myers MG | Intussusception, Rotavirus, and Oral Vaccines: Summary of a Workshop | Pediatrics 2002 Dec; 110 (6): e67 |
| Pediatrics | 2003 | RSV immune globulin | American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. | Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. | Pediatrics. 2003 Dec;112(6 Pt 1):1442-6. |
| Pediatrics | 2003 | Respiratory syncytial virus immune globulin | Meissner HC, Long SS; American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn | Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections | Pediatrics. 2003 Dec;112(6 Pt 1):1447-52 |
| Pediatrics | 2004 | Recombinant human activated protein C (drotrecogin alfa [activated]) | Barton P, Kalil AC, Nadel S, Goldstein B, Okhuysen-Cawley R, Brilli RJ, Takano JS, Martin LD, Quint P, Yeh TS, Dalton HJ, Gessouron MR, Brown KE, Betts H, Levin M, Macias WL, Small DS, Wyss VL, Bates BM, Utterback BG, Giroir BP. | Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis | Pediatrics. 2004 Jan;113(1 Pt 1):7-17 |
| Pediatrics | 2005 | Rifampin | Kiang KM, Ogunmodede F, Juni BA, Boxrud DJ, Glennen A, Bartkus JM, Cebelinski EA, Harriman K, Koop S, Faville R, Danila R, Lynfield R | Outbreak of osteomyelitis/septic arthritis caused by Kingella kingae among child care center attendees | Pediatrics. 2005 Aug;116(2):e206-13 |
| Pediatrics | 2005 | Rizatriptan | Damen L, Bruijn JK, Verhagen AP, Berger MY, Passchier J, Koes BW | Symptomatic treatment of migraine in children: a systematic review of medication trials | Pediatrics. 2005 Aug;116(2):e295-302 |
| Pediatrics | 2006 | Ringer's lactate | American Heart Association | 2005 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: pediatric advanced life support | Pediatrics. 2006 May;117(5):e1005-28 |